ArticleCancers2021

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.

Elisa Conde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.